TY - JOUR AU - Balis, F. M. PY - 2002 DA - 2002// TI - Evolution of anticancer drug discovery and the role of cell-based screening JO - J Natl Cancer Inst VL - 94 UR - https://doi.org/10.1093/jnci/94.2.78 DO - 10.1093/jnci/94.2.78 ID - Balis2002 ER - TY - JOUR AU - Schilsky, R. L. PY - 2002 DA - 2002// TI - End points in cancer clinical trials and the drug approval process JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 8 ID - Schilsky2002 ER - TY - JOUR AU - Rothenberg, M. L. AU - Carbone, D. P. AU - Johnson, D. H. PY - 2003 DA - 2003// TI - Improving the evaluation of new cancer treatments: challenges and opportunities JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1047 DO - 10.1038/nrc1047 ID - Rothenberg2003 ER - TY - STD TI - FDA. US: Draft Drug Diagnostic Co-Development Preliminary Concept Paper. Available at http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm116689.pdf. 2011. UR - http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm116689.pdf ID - ref4 ER - TY - STD TI - FDA. US: In Vitro Companion Diagnostic Devices. Available at http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm. UR - http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm ID - ref5 ER - TY - STD TI - FDA. US: Guidance for Industry Expedited Programs for Serious Conditions -- Drugs and Biologics. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf. UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf ID - ref6 ER - TY - STD TI - Therapies. FoCRB. Available at http://www.focr.org/breakthrough-therapies. UR - http://www.focr.org/breakthrough-therapies ID - ref7 ER - TY - JOUR AU - Scher, H. I. AU - Nasso, S. F. AU - Rubin, E. H. AU - Simon, R. PY - 2011 DA - 2011// TI - Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-1105 DO - 10.1158/1078-0432.CCR-11-1105 ID - Scher2011 ER - TY - JOUR AU - Hirsch, R. AU - Dent, C. AU - Pfriem, H. AU - Allen, J. AU - Beekman, R. H. AU - Ma, Q. PY - 2007 DA - 2007// TI - NGAL is an early predictive biomarker of contrast-induced nephropathy in children JO - Pediatr Nephrol VL - 22 UR - https://doi.org/10.1007/s00467-007-0601-4 DO - 10.1007/s00467-007-0601-4 ID - Hirsch2007 ER - TY - JOUR AU - Parikh, C. R. AU - Mishra, J. AU - Thiessen-Philbrook, H. AU - Dursun, B. AU - Ma, Q. AU - Kelly, C. PY - 2006 DA - 2006// TI - Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery JO - Kidney Int VL - 70 UR - https://doi.org/10.1038/sj.ki.5001527 DO - 10.1038/sj.ki.5001527 ID - Parikh2006 ER - TY - JOUR AU - Freidlin, B. AU - Simon, R. PY - 2005 DA - 2005// TI - Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0605 DO - 10.1158/1078-0432.CCR-05-0605 ID - Freidlin2005 ER - TY - JOUR AU - Jiang, W. AU - Freidlin, B. AU - Simon, R. PY - 2007 DA - 2007// TI - Biomarker-adaptive threshold design: a procedure for evaluating treatment with possible biomarker-defined subset effect JO - J Natl Cancer Inst VL - 99 UR - https://doi.org/10.1093/jnci/djm022 DO - 10.1093/jnci/djm022 ID - Jiang2007 ER - TY - JOUR AU - Taube, S. E. AU - Clark, G. M. AU - Dancey, J. E. AU - McShane, L. M. AU - Sigman, C. C. AU - Gutman, S. I. PY - 2009 DA - 2009// TI - A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp334 DO - 10.1093/jnci/djp334 ID - Taube2009 ER - TY - JOUR AU - Freidlin, B. AU - Jiang, W. AU - Simon, R. PY - 2010 DA - 2010// TI - The cross-validated adaptive signature design JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-1357 DO - 10.1158/1078-0432.CCR-09-1357 ID - Freidlin2010 ER - TY - STD TI - Wang S-J, Li M-C: Impacts of Predictive Genomic Classifier Performance on Subpopulation-Specific Treatment Effects Assessment. Stat Biosciences. 2014. http://link.springer.com/article/10.1007%2Fs12561-013-9092-y. UR - http://link.springer.com/article/10.1007%2Fs12561-013-9092-y ID - ref15 ER - TY - JOUR AU - Jenkins, M. AU - Flynn, A. AU - Smart, T. AU - Harbron, C. AU - Sabin, T. AU - Ratnayake, J. PY - 2011 DA - 2011// TI - A statistician's perspective on biomarkers in drug development JO - Pharm Stat VL - 10 UR - https://doi.org/10.1002/pst.532 DO - 10.1002/pst.532 ID - Jenkins2011 ER - TY - JOUR AU - Buyse, M. AU - Michiels, S. AU - Sargent, D. J. AU - Grothey, A. AU - Matheson, A. AU - Gramont, A. PY - 2011 DA - 2011// TI - Integrating biomarkers in clinical trials JO - Expert Rev Mol Diagn VL - 11 UR - https://doi.org/10.1586/erm.10.120 DO - 10.1586/erm.10.120 ID - Buyse2011 ER - TY - STD TI - FDA. US: Guidance for Industry Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM332181.pdf. UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM332181.pdf ID - ref18 ER - TY - BOOK AU - McCullagh, P. AU - Nelder, J. PY - 1989 DA - 1989// TI - Generalized Linear Model, 2nd Edition PB - Chapman, Hall CY - London UR - https://doi.org/10.1007/978-1-4899-3242-6 DO - 10.1007/978-1-4899-3242-6 ID - McCullagh1989 ER - TY - BOOK AU - Cox, D. AU - Oakes, D. PY - 1984 DA - 1984// TI - Analysis of survival data PB - Chapman Hall CY - London ID - Cox1984 ER - TY - JOUR AU - Breiman, L. PY - 2001 DA - 2001// TI - Random forests JO - Mach Learn VL - 45 UR - https://doi.org/10.1023/A:1010933404324 DO - 10.1023/A:1010933404324 ID - Breiman2001 ER - TY - BOOK AU - Vapnik, V. PY - 1995 DA - 1995// TI - The nature of statistical learning theory PB - Springer CY - New York UR - https://doi.org/10.1007/978-1-4757-2440-0 DO - 10.1007/978-1-4757-2440-0 ID - Vapnik1995 ER - TY - JOUR AU - Guyon, I. AU - Weston, J. AU - Barnhill, S. AU - Vapnik, V. PY - 2002 DA - 2002// TI - Gene selection for cancer classification using support vector machines JO - Mach Learn VL - 46 UR - https://doi.org/10.1023/A:1012487302797 DO - 10.1023/A:1012487302797 ID - Guyon2002 ER - TY - JOUR AU - Dudoit, S. AU - Fridlyand, J. AU - Speed, T. PY - 2002 DA - 2002// TI - Comparison of discrimination methods for the classification of tumors using gene expression data JO - J Am Stat Assoc VL - 97 UR - https://doi.org/10.1198/016214502753479248 DO - 10.1198/016214502753479248 ID - Dudoit2002 ER - TY - JOUR AU - Moon, H. AU - Ahn, H. AU - Kodell, R. L. AU - Baek, S. AU - Lin, C. J. AU - Chen, J. J. PY - 2007 DA - 2007// TI - Ensemble methods for classification of patients for personalized medicine with high-dimensional data JO - Artif Intell Med VL - 41 UR - https://doi.org/10.1016/j.artmed.2007.07.003 DO - 10.1016/j.artmed.2007.07.003 ID - Moon2007 ER - TY - JOUR AU - Baek, S. AU - Tsai, C. A. AU - Chen, J. J. PY - 2009 DA - 2009// TI - Development of biomarker classifiers from high-dimensional data JO - Brief Bioinform VL - 10 UR - https://doi.org/10.1093/bib/bbp016 DO - 10.1093/bib/bbp016 ID - Baek2009 ER - TY - JOUR AU - Lin, W. J. AU - Chen, J. J. PY - 2012 DA - 2012// TI - Biomarker classifiers for identifying susceptible subpopulations for treatment decisions JO - Pharmacogenomics VL - 13 UR - https://doi.org/10.2217/pgs.11.139 DO - 10.2217/pgs.11.139 ID - Lin2012 ER - TY - JOUR AU - Lu, T. P. AU - Chen, J. J. PY - 2015 DA - 2015// TI - Identification of drug-induced toxicity biomarkers for treatment determination JO - Pharm Stat VL - 14 UR - https://doi.org/10.1002/pst.1684 DO - 10.1002/pst.1684 ID - Lu2015 ER - TY - STD TI - Hastie T, Tibshirani R, Friedman J: The Elements of Statistical Learning: Data Mining, Inference, and Prediction: Springer. Spring Science + Business Media, LLC.; 2001. http://statweb.stanford.edu/~tibs/ElemStatLearn/. UR - http://statweb.stanford.edu/~tibs/ElemStatLearn/ ID - ref29 ER - TY - JOUR AU - Chen, D. T. AU - Hsu, Y. L. AU - Fulp, W. J. AU - Coppola, D. AU - Haura, E. B. AU - Yeatman, T. J. PY - 2011 DA - 2011// TI - Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djr420 DO - 10.1093/jnci/djr420 ID - Chen2011 ER - TY - JOUR AU - Chen, H. C. AU - Kodell, R. L. AU - Cheng, K. F. AU - Chen, J. J. PY - 2012 DA - 2012// TI - Assessment of performance of survival prediction models for cancer prognosis JO - BMC Med Res Methodol VL - 12 UR - https://doi.org/10.1186/1471-2288-12-102 DO - 10.1186/1471-2288-12-102 ID - Chen2012 ER - TY - JOUR AU - Shedden, K. AU - Taylor, J. M. AU - Enkemann, S. A. AU - Tsao, M. S. AU - Yeatman, T. J. AU - Gerald, W. L. PY - 2008 DA - 2008// TI - Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm.1790 DO - 10.1038/nm.1790 ID - Shedden2008 ER - TY - JOUR AU - Zhu, C. Q. AU - Ding, K. AU - Strumpf, D. AU - Weir, B. A. AU - Meyerson, M. AU - Pennell, N. PY - 2010 DA - 2010// TI - Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.4325 DO - 10.1200/JCO.2009.26.4325 ID - Zhu2010 ER - TY - STD TI - Mogensen UB, Ishwaran H, Gerds TA: Evaluating Random Forests for Survival Analysis Using Prediction Error Curves. J Stat Software. 2012;50(11):1–23. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194196/. UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194196/ ID - ref34 ER - TY - JOUR AU - Wang, S. J. AU - Hung, H. M. AU - O'Neill, R. T. PY - 2009 DA - 2009// TI - Adaptive patient enrichment designs in therapeutic trials JO - Biometrical J Biometrische Zeitschrift VL - 51 UR - https://doi.org/10.1002/bimj.200900003 DO - 10.1002/bimj.200900003 ID - Wang2009 ER - TY - JOUR AU - Millen, B. A. AU - Dmitrienko, A. AU - Ruberg, S. J. AU - Shen, L. PY - 2012 DA - 2012// TI - A statistical framework for decision making in confirmatory multipopulation tailoring clinical trials JO - Drug Inform J VL - 46 ID - Millen2012 ER - TY - STD TI - Harmonization ICo: International Conference on Harmonization (ICH) guidance, E9 Statistical Principles for Clinical Trials (ICH E9 guidance). February. available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf. 1998. UR - http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf ID - ref37 ER - TY - JOUR AU - Foster, J. C. AU - Taylor, J. M. AU - Ruberg, S. J. PY - 2011 DA - 2011// TI - Subgroup identification from randomized clinical trial data JO - Stat Med VL - 30 UR - https://doi.org/10.1002/sim.4322 DO - 10.1002/sim.4322 ID - Foster2011 ER - TY - JOUR AU - Kehl, V. AU - Ulm, K. PY - 2006 DA - 2006// TI - Responder identification in clinical trials with censored data JO - Comput Stat Data Analysis VL - 50 UR - https://doi.org/10.1016/j.csda.2004.11.015 DO - 10.1016/j.csda.2004.11.015 ID - Kehl2006 ER - TY - JOUR AU - Lipkovich, I. AU - Dmitrienko, A. AU - Denne, J. AU - Enas, G. PY - 2011 DA - 2011// TI - Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations JO - Stat Med VL - 30 ID - Lipkovich2011 ER - TY - JOUR AU - Lipkovich, I. AU - Dmitrienko, A. PY - 2014 DA - 2014// TI - Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES JO - J Biopharm Stat VL - 24 UR - https://doi.org/10.1080/10543406.2013.856024 DO - 10.1080/10543406.2013.856024 ID - Lipkovich2014 ER - TY - JOUR AU - Berger, J. O. AU - Wang, X. AU - Shen, L. PY - 2014 DA - 2014// TI - A Bayesian approach to subgroup identification JO - J Biopharm Stat VL - 24 UR - https://doi.org/10.1080/10543406.2013.856026 DO - 10.1080/10543406.2013.856026 ID - Berger2014 ER - TY - JOUR AU - Stallard, N. AU - Hamborg, T. AU - Parsons, N. AU - Friede, T. PY - 2014 DA - 2014// TI - Adaptive designs for confirmatory clinical trials with subgroup selection JO - J Biopharm Stat VL - 24 UR - https://doi.org/10.1080/10543406.2013.857238 DO - 10.1080/10543406.2013.857238 ID - Stallard2014 ER - TY - JOUR AU - Ruberg, S. J. AU - Chen, L. AU - Wang, Y. PY - 2010 DA - 2010// TI - The mean does not mean as much anymore: finding sub-groups for tailored therapeutics JO - Clin Trials VL - 7 UR - https://doi.org/10.1177/1740774510369350 DO - 10.1177/1740774510369350 ID - Ruberg2010 ER - TY - JOUR AU - Su, X. AU - Tsai, C. L. AU - Wang, H. AU - Nickerson, D. M. AU - Bogong, L. PY - 2009 DA - 2009// TI - Subgroup analysis via recursive partitioning JO - J Machine Learn Res VL - 10 ID - Su2009 ER -